Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruxandra Pinto

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|November 6, 2014
Clinical presentation of patients with Ebola virus disease in Conakry, GuineaElhadj Ibrahima Bah, Marie-Claire Lamah, Tom Fletcher, et al.
JAMA|November 2, 2014
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patientsRobert A Fowler, Nicole Mittmann, William Geerts, et al.
American Journal of Respiratory and Critical Care Medicine|November 22, 2017
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeYaseen M Arabi, Yasser Mandourah, Fahad Al-Hameed, et al.
Trials|December 22, 2014
Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trialRobert A Fowler, Nicole Mittmann, William H Geerts, et al.
The Lancet. Respiratory Medicine|February 24, 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Benjamin Speich, France Mentré, et al.
Eclinicalmedicine|April 21, 2025
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trialSean W X Ong, Ruxandra Pinto, Asgar Rishu, et al.
CMAJ Open|October 6, 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trialVincent I Lau, Robert Fowler, Ruxandra Pinto, et al.
JMIR Research Protocols|April 14, 2022
Lessening Organ Dysfunction With Vitamin C (LOVIT) Trial: Statistical Analysis PlanNeill Kj Adhikari, Ruxandra Pinto, Andrew G Day, et al.
Trials|January 10, 2020
Lessening Organ dysfunction with VITamin C (LOVIT): protocol for a randomized controlled trialMarie-Hélène Masse, Julie Ménard, Sheila Sprague, et al.
Critical Care Medicine|July 1, 2016
Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014Guillermo Dominguez-Cherit, Alethse De la Torre, Asgar Rishu, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|November 6, 2014
Clinical presentation of patients with Ebola virus disease in Conakry, GuineaElhadj Ibrahima Bah, Marie-Claire Lamah, Tom Fletcher, et al.
JAMA|November 2, 2014
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patientsRobert A Fowler, Nicole Mittmann, William Geerts, et al.
American Journal of Respiratory and Critical Care Medicine|November 22, 2017
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeYaseen M Arabi, Yasser Mandourah, Fahad Al-Hameed, et al.
Trials|December 22, 2014
Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trialRobert A Fowler, Nicole Mittmann, William H Geerts, et al.
The Lancet. Respiratory Medicine|February 24, 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Benjamin Speich, France Mentré, et al.
Eclinicalmedicine|April 21, 2025
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trialSean W X Ong, Ruxandra Pinto, Asgar Rishu, et al.
CMAJ Open|October 6, 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trialVincent I Lau, Robert Fowler, Ruxandra Pinto, et al.
JMIR Research Protocols|April 14, 2022
Lessening Organ Dysfunction With Vitamin C (LOVIT) Trial: Statistical Analysis PlanNeill Kj Adhikari, Ruxandra Pinto, Andrew G Day, et al.
Trials|January 10, 2020
Lessening Organ dysfunction with VITamin C (LOVIT): protocol for a randomized controlled trialMarie-Hélène Masse, Julie Ménard, Sheila Sprague, et al.
Critical Care Medicine|July 1, 2016
Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014Guillermo Dominguez-Cherit, Alethse De la Torre, Asgar Rishu, et al.
Pageof 19